Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancerZhiqiang Han(Tongji Hospital), Zhenya Hong(Tongji Hospital)OncotargetAugust 6, 201410.18632/oncotarget.2314Cited by 63SaveCiteExport RISWatch citationsRelated PapersA novel oncolytic adenovirus selectively silences the expression of tumor-associated STAT3 and exhibits potent antitumoral activity|Carcinogenesis|2009|22